Ethambutol Hydrochloride/Rifampicin/Isoniazid

盐酸乙胺丁醇/利福平/异烟肼

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEthambutol Hydrochloride/Rifampicin/Isoniazid
Drug Alias Name利福平/异烟肼/盐酸乙胺丁醇Rifampicin/Isoniazid/Ethambutol Hydrochloride盐酸乙胺丁醇/异烟肼/利福平Ethambutol Hydrochloride/Isoniazid/Rifampicin安思诺康
ClassificationSmall molecules
Mechanisms of ActionDNA-directed RNA polymerase beta chain inhibitorsBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymeraseDNA-directed RNA polymerase beta chain
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsTuberculosis
Approved Indications in ChinaTuberculosis
Original Approved Country/TerritoryMainland China
Original Approved Date2008/03/03
Country/TerritoryMainland China
CombinationsYes Ethambutol HydrochlorideRifampicinIsoniazid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenyang Hongqi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Hongqi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeJ04AM07
Related LinksN/A